GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ICU Medical Inc (NAS:ICUI) » Definitions » Beneish M-Score

ICUI (ICU Medical) Beneish M-Score : -2.64 (As of Jun. 29, 2025)


View and export this data going back to 1992. Start your Free Trial

What is ICU Medical Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.64 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for ICU Medical's Beneish M-Score or its related term are showing as below:

ICUI' s Beneish M-Score Range Over the Past 10 Years
Min: -3.1   Med: -2.51   Max: -0.09
Current: -2.64

During the past 13 years, the highest Beneish M-Score of ICU Medical was -0.09. The lowest was -3.10. And the median was -2.51.


ICU Medical Beneish M-Score Historical Data

The historical data trend for ICU Medical's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ICU Medical Beneish M-Score Chart

ICU Medical Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.00 -2.96 -1.68 -2.94 -2.75

ICU Medical Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.72 -2.85 -2.77 -2.75 -2.64

Competitive Comparison of ICU Medical's Beneish M-Score

For the Medical Instruments & Supplies subindustry, ICU Medical's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ICU Medical's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ICU Medical's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where ICU Medical's Beneish M-Score falls into.


;
;

ICU Medical Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of ICU Medical for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.1295+0.528 * 0.9251+0.404 * 0.9518+0.892 * 1.0722+0.115 * 0.8542
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9732+4.679 * -0.056369-0.327 * 1.0323
=-2.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar25) TTM:Last Year (Mar24) TTM:
Total Receivables was $205 Mil.
Revenue was 604.702 + 629.805 + 589.131 + 596.455 = $2,420 Mil.
Gross Profit was 210.109 + 227.258 + 204.852 + 207.428 = $850 Mil.
Total Current Assets was $1,424 Mil.
Total Assets was $4,185 Mil.
Property, Plant and Equipment(Net PPE) was $503 Mil.
Depreciation, Depletion and Amortization(DDA) was $213 Mil.
Selling, General, & Admin. Expense(SGA) was $638 Mil.
Total Current Liabilities was $549 Mil.
Long-Term Debt & Capital Lease Obligation was $1,539 Mil.
Net Income was -15.476 + -23.828 + -32.983 + -21.406 = $-94 Mil.
Non Operating Income was -18.46 + -14.38 + -14.362 + -20.181 = $-67 Mil.
Cash Flow from Operations was 51.327 + 40.192 + 36.097 + 81.953 = $210 Mil.
Total Receivables was $169 Mil.
Revenue was 566.655 + 587.856 + 553.311 + 549.31 = $2,257 Mil.
Gross Profit was 185.244 + 171.585 + 183.92 + 192.327 = $733 Mil.
Total Current Assets was $1,188 Mil.
Total Assets was $4,288 Mil.
Property, Plant and Equipment(Net PPE) was $670 Mil.
Depreciation, Depletion and Amortization(DDA) was $229 Mil.
Selling, General, & Admin. Expense(SGA) was $612 Mil.
Total Current Liabilities was $455 Mil.
Long-Term Debt & Capital Lease Obligation was $1,618 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(204.675 / 2420.093) / (169 / 2257.132)
=0.084573 / 0.074874
=1.1295

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(733.076 / 2257.132) / (849.647 / 2420.093)
=0.324782 / 0.35108
=0.9251

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1423.915 + 503.329) / 4184.581) / (1 - (1187.727 + 670.121) / 4288.398)
=0.539442 / 0.566773
=0.9518

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=2420.093 / 2257.132
=1.0722

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(228.6 / (228.6 + 670.121)) / (213.431 / (213.431 + 503.329))
=0.254361 / 0.297772
=0.8542

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(638.338 / 2420.093) / (611.778 / 2257.132)
=0.263766 / 0.271042
=0.9732

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((1539.141 + 549.024) / 4184.581) / ((1617.705 + 455.36) / 4288.398)
=0.499014 / 0.483412
=1.0323

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-93.693 - -67.383 - 209.569) / 4184.581
=-0.056369

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

ICU Medical has a M-score of -2.64 suggests that the company is unlikely to be a manipulator.


ICU Medical Beneish M-Score Related Terms

Thank you for viewing the detailed overview of ICU Medical's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


ICU Medical Business Description

Traded in Other Exchanges
N/A
Address
951 Calle Amanecer, San Clemente, CA, USA, 92673
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.
Executives
Christian B. Voigtlander officer: Chief Operating Officer 951 CALLE AMANECER, SAN CLEMENTE CA 92673
Elisha W Finney director C/O VARIAN MEDICAL SYSTEMS, INC, 3100 HANSEN WAY M/S E-327, PALO ALTO CA 94304
David C. Greenberg director 951 CALLE AMANECER, SAN CLEMENTE CA 92887
Vivek Jain director, officer: Chairman and CEO ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673
Daniel Woolson officer: VP, GM-Infusion Capital ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673
Virginia Ruth Sanzone officer: VP, General Counsel 951 CALLE AMANECER, SAN CLEMENTE CA 92673
George A Lopez director, officer: Chairman, other: Chairman C/O ICU MEDICAL, 951 CALLE AMANECER, SAN CLEMENTE CA 92673
Smiths Group International Holdings Ltd 10 percent owner C/O SMITHS GROUP PLC, 11-12 ST. JAMES'S SQUARE, 4TH FLOOR, LONDON X0 SW1Y 4LB
Group Plc Smiths 10 percent owner 765 FINCHKEY ROAD, LONDON X0 00000
William Seeger director 951 CALLE AMANECER, SAN CLEMENTE CA 92673
Kolleen T Kennedy director VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304
Robert S Swinney director C/O ICU MEDICAL, 951 CALLE AMANECER, SAN CLEMENTE CA 92673
Laurie Hernandez director 951 CALLE AMANECER, SAN CLEMENTE CA 92673
Brian Michael Bonnell officer: Chief Financial Officer ICU MEDICAL INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673
Scott E Lamb officer: Controller ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673